This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Lifshitz Law Firm Announces Investigation Of Atossa Genetics, Inc., Francesca's Holdings Corporation, Greenway Medical Technologies, Inc., And PVR Partners, L.P.

NEW YORK, Oct. 12, 2013 /PRNewswire/ --

Atossa Genetics, Inc. Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty by the board of directors of Atossa Genetics, Inc. ("Atossa" or the "Company").  On October 4, 2013, Atossa announced it had commenced the voluntary recall of the ForeCYTE Breast Health Test Mammary Aspiration Specimen Cytology Test.  In February 2013, the Company received a warning letter from the FDA.  The FDA raised concerns about (1) the current instructions for use ("IFU"); (2) certain promotional claims used to market these devices; and (3) the need for FDA clearance for certain changes made to the Nipple Aspirate Fluid specimen collection process identified in the current IFU.  Atossa will remove existing product from the market until FDA's concerns are addressed.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Francesca's Holdings Corporation  Lifshitz Law Firm announces that a class action suit was filed in the United States District Court for the Southern District of New York, alleging that Francesca's Holdings Corporation ("FRAN") issued false and misleading statements to investors between March 20, 2013 and September 3, 2013, inclusive (the "Class Period") by failing to disclose that: (i) spring and summer weather and a competitive back-to-school retail environment weighed on same-store sales growth; and (ii) same-store sales were declining.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Greenway Medical Technologies, Inc.  Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Greenway Medical Technologies, Inc. ("GWAY") to Vista Equity Partners in a transaction valued at approximately $644 million or $20.35 per share in cash.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to GWAY's shareholders.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,955.19 -115.21 -0.64%
S&P 500 2,095.57 -18.92 -0.89%
NASDAQ 4,946.2290 -70.70 -1.41%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs